Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Q&A: Merck's Kevin Nalty, YouTube Star, Explains Why He Quit
- Kevin Nalty was Merck's consumer product director on Propecia until last week when he quit after a series of videos he posted on YouTube drew too much attention to the drug company. The move came after it emerged that he was “Nalts,†the creator of a YouTube video titled “Farting...
- Blog posts 2009-05-27
Additional Resources
- Los accidentes reinaron en Nueva Zelanda y Australia. (Deportivas).(carreras de automoviles)(Rally Propecia; Rally Telstra )(Articulo breve)
- Rally Propecia de Nueva Zelanda 2002 Rally Propecia de Nueva Zelanda 2002
- Research articles 2003-01-01
- Merck's Propecia ad in 'misleading'
- * Merck's print ad in the March 30 issue of Time Magazine for its hair growth pill, Propecia, was "misleading" because it implied that the drug is "useful in a broader range of conditions," warned the DDMAC review officer Mark Askine in a letter to the company. Merck failed to...
- Research articles 1998-06-01
- Databank health: Rogaine's loss is propecia's gain(e).(Internet advertsing)(Brief Article)
- Hair loss, asthma and arthritis pain medications are the leading pharmaceutical products being advertised on the Web. According to data from New York-based Jupiter Media Metrix's AdRelevance, Merck & Co.'s Propecia hair-loss treatment led the sec Hair loss, asthma and arthritis pain medications are the leading...
- Research articles 2001-07-16
- Merck kicks off $60 mil DTC push for Rogaine rival.(direct-to-consumer, Propecia)
- Merck & Co. today breaks an estimated $50 million to s6o million direct-to-consumer ad campaign for its prescription hair-loss treatment Propecia. Merck & Co. today breaks an estimated $50 million to s6o million direct-to-consumer ad campaign for its prescription hair-loss treatment Propecia.
- Research articles 1998-04-20
- Merck & Co. Inc.(Brief Article)
- 00-00-0000 With a hefty 7.5% of sales invested in R&D, Merck keeps a flow of new drugs surging through its pipeline, including four new introductions this year: Propecia, for hair loss; Singulair, for asthma; Maxalt, for migraines; and Aggra 00-00-0000 With a hefty...
- Research articles 1998-08-17
- FOCUS ON THE FOLLICLES
- Colorado Avalanche goalie Jose Theodore isn't worried about being the focal point of Jose Canseco's next tell-all book. Yes, Theodore tested positive for a banned substance in screening prior to the Winter Olympics. But no, it wasn't for steroids. It was for finasteride --...
- Research articles 2006-04-24
- To win hearts of Japanese men, focus on their hair.(The World)(Banyu Merck's Propecia)
- Byline: Dave McCaughan Byline: Dave McCaughan
- Research articles 2007-10-15
- GSK Has Hand in Gene-Based 'Baldness Cure'
- This is going to be big news -- even though from a science point of view, it's not big news: Scientists have found two genes in the human DNA strand that may be correlated with male hair loss. The business angle is that GlaxoSmithKline has a hand in the research....
- Blog posts 2008-10-14
- NHL goalie Theodore tests positive for making agent
- MONTREAL AFP — Montreal Canadiens goaltender Jose Theodore tested positive for a masking agent banned by the World Anti-Doping Agency, the National Hockey League club said. Team doctor David Mulder said Theodore tested positive for Propecia, a hair restoration drug also known as finasteride. It's the same drug...
- Research articles 2006-02-10
- LEN TACCONI
- Merck & Co. Title: Executive director-consumer marketing Ad budget: $122 million Agency roster: Ogilvy & Mather Worldwide, Y&R Advertising, Foote, Cone & Belding and Prime Access Power play: Launched Propecia and will increase spending with the launches of Maxalt migraine remedy and Vioxx, the...
- Research articles 1998-10-05
- The Internet Analyst News - Hair Loss: New Tools to Fight Baldness-Pharmacia & Upjohn's Rogaine And Products From Other Companies
- NEW YORK--BUSINESS WIRE--Oct. 12, 1999-- Pharmacia & Upjohn's (NYSE-PNU) Rogaine is an over-the-counter product that is available in two strengths (2% and 5%) for men, and in one strength (2%) for women. Merck & Co.'s (NYSE-MRK) Propecia is an oral remedy that is taken once-a-day and is available...
- Research articles 1999-10-12
- Merck Exec Quits After YouTube Gross-Out Video Got Too Much Negative Attention
- Kevin Nalty, Merck's consumer product director for Propecia, quit his job last week. The move came after it emerged that he was "Nalts," the creator of a YouTube video titled "Farting in Public" that has earned more than 7.4 million views on YouTube. by Jim Edwards
- Blog posts 2009-05-23
- Lund's hairy mess now behind him
- PARK CITY -- Salt Lake's Zach Lund was back on the track he knows by heart, this week, 10 months after being derailed by a rampant case of, well, hair-splitting. Not only was he back, he was winning. He claimed his first-ever World Cup gold medal in Thursday's skeleton competition...
- Research articles 2006-12-10
- Room at the top? Propecia and Roagaine fight to fill it
- Did you see the Rogaine game on New Year's Day? Pharmacia & Upjohn scheduled nine TV ads for its newly released 5% solution during three football bowl contests on ABC. Jordan, McGrath, Case & Taylor is the agency for Rogaine. It is expected to employ a $50-million-plus budget during...
- Research articles 1998-01-01
- Propecia Rally New Zealand: SS1.
- SS1 - Manukau Super 1 (2.10 kms): Martin fastest through SS1; Gronholm second; Duval third; Solberg fourth; Hirvonen and Rovanpera joint fifth; Nutahara heads the PCWRC category; Martin leads the overall event by 0.4secs. Stage times and overall standings after SS1. Top ten stage times for SS1: ...
- Research articles 2004-04-15
- << Previous
- page 1 of 1
- Next >>
